Takeru Kashiwada

DOCK2 is involved in the host genetics and biology of severe COVID-19

Ho Namkoong, Ryuya Edahiro, Tomomi Takano et al. · Nature · 2022 · 97 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Exosome-Derived <i>microRNA</i>-<i>22</i> Ameliorates Pulmonary Fibrosis by Regulating Fibroblast-to-Myofibroblast Differentiation <i>in Vitro</i> and <i>in Vivo</i>

Naoyuki Kuse, Koichiro Kamio, Arata Azuma et al. · Journal of Nippon Medical School · 2019 · 74 citations · Full text

Life Sciences, Molecular Biology, Pathology +16

Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity

Ryuya Edahiro, Yuya Shirai, Yusuke Takeshima et al. · Nature Genetics · 2023 · 69 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation

Koichiro Kamio, Arata Azuma, Kuniko Matsuda et al. · Respiratory Research · 2018 · 55 citations · Full text

Life Sciences, Immunology, Pathology +16

β-catenin-dependent transcription is central to Bmp-mediated formation of venous vessels

Takeru Kashiwada, Shigetomo Fukuhara, Kenta Terai et al. · Development · 2015 · 52 citations

Life Sciences, Developmental Biology, Molecular Biology +17